What You Should Know:
– Circular Genomics, a pioneer in unlocking the secrets of circular RNA (circRNA) for precision psychiatry and neurology, has secured $8.3 million in a Series A funding round. Led by Mountain…
Continue Reading
What You Should Know:
– Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
– Under the terms of the agreement, Veracyte will pay $70…
Continue Reading
What You Should Know: Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services, today announced a collaboration involving Ultima’s next generation sequencing…
Continue Reading
When people think of genomics, they typically don’t visualize the primary care setting — but Northshore–Edward Elmhurst Health is trying to change that.
Genomics is a key part of the health system’s approach to personalized care…
What You Should Know:
– Cone Health, a non-profit healthcare network in North Carolina, and Helix, a population genomics company, have partnered to launch a five-year research study that will enroll and track 100,000 healthy…
Continue Reading
What You Should Know:
Cercle, an AI technology company unlocking comprehensive and secure data insights for the healthcare industry, announced its launch today. Its technology platform, the Cercle™ Biomedical Graph, is the first and only of…
Continue Reading
What You Should Know: Verana Health® (Verana), a digital health company helping to revolutionize patient care and clinical research by unlocking the potential of real-world data, and the Foundation Fighting Blindness – the world’s leading organization committed…
Continue Reading
NUS Medicine has partnered with GigXR to introduce a cutting-edge holographic mixed reality (MR) training module for acute gastrointestinal disease diagnosis and treatment. Fujitsu and Toppan have joined forces to offer advanced big data…
Continue Reading
Jordan Sollof is joined by Richard Scott, chief medical officer, acting CEO and soon to be the new interim CEO of Genomics England, to chat about the work the organisation does and how AI…
Continue Reading
Richard Scott, chief medical officer, acting CEO and soon to be the new interim CEO of Genomics England, has delved deep into the work the organisation does and how AI fits in ahead of…
Continue Reading
